A recent paper by Emmy Boerrigter, Pharmacist at Radboudumc Research Institute for Medical Innovation, was mentioned by European Urology Oncology on X:
“A Prospective Randomised Trial to Determine the Effect of a Reduced Versus Standard Dose of Enzalutamide on Side Effects in Frail Patients with PCa by Emmy Boerrigter, Joanneke K. Overbeek et al.”
Authors: Emmy Boerrigter, Joanneke Overbeek, Guillemette Benoist, Inge van Oort, Nielka van Erp et al.
More posts featuring European Urology Oncology.